Do you have the same question? Follow this Question
Jun 11, 2026 - 08:26 AM
We’ve provided several answers to questions related to Simponi (Golimumab) , see some other helpful Q&A related to this product.
Question: Is protein binding significant for this medication?
Answer: Protein binding is not significant for this drug. Low protein binding reduces the risk of drug interactions and variability in effectiveness among patients.
Question: What is the legal status of this medication?
Answer: This medication is available by prescription only. Prescription-only status ensures that use is monitored by a healthcare provider, which is especially important due to its potent effects and potential risks.
Question: What is the standard dosage for rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis?
Answer: The typical dosage for these conditions is 50 mg once a month. Monthly dosing is convenient and helps improve adherence for people with chronic conditions.
